Semax + Selank blend: research, legal status and who sells it
This page is information, not medical advice. Semax + Selank blend is not approved as a medicine in the markets below unless stated. We don't publish dosing or usage instructions.
- Also known as
- Semax and selank blend
- Category
- Blend of semax (an ACTH(4-10) analogue) and selank (a tuftsin analogue)
- Evidence level
- Early human trials
- Price range
- $1.75/mg to $7.86/mg, median $4.81/mg across 19 vendors (compare)
- Our lab tests
- None yet (how testing will work)
Legal and regulatory status
| Where | Status |
|---|---|
| United States | Neither semax nor selank is FDA-approved, and no approved product combines them [1]. |
| United Kingdom | No UK-licensed medicine contains either peptide [2][3]. |
| European Union | No medicine containing semax or selank is authorized in the EU, according to EMA's central and Article 57 product data [4][5]. |
| Canada | No product containing semax or selank appears in Health Canada's Drug Product Database [6]. |
| Australia | Neither semax nor selank is named in Australia's Poisons Standard (October 2026) [7]. |
| Sport (WADA) | Neither semax nor selank is named on the 2026 Prohibited List [8]. |
We haven't published a full overview of Semax + Selank blend yet. The legal status table and live prices on this page are current.
Semax + Selank blend prices: cheapest listings
The five lowest $/mg listings out of 25. See all Semax + Selank blend prices
| Vendor | Transparency | Product | Size | Price | $/mg | Stock | Vendor's page |
|---|---|---|---|---|---|---|---|
| Bulk Peptide Supply | 57 | Selank / Semax 10 mg/10 mg (10 vials) | 20 mg × 10 | $350 | $1.75/mg | View | |
| PS Peptides | 22 | Selank+Semax Blend (1 Vial) – Subscription | 40 mg | $117 | $2.92/mg | View | |
| EZ Peptides | 75 | Semax + Selank Blend · 10mg + 10mg | 20 mg | $63 | $3.15/mg | View | |
| Panda Peptide | 50 | Selank + Semax Blend 10mg/10mg | 20 mg | CA$100 | $3.52/mg | View | |
| AIO Peptides | 52 | Selank/Semax 10mg/10mg | 20 mg | $74 | $3.67/mg | View |
Sources
- Drugs@FDA: FDA-Approved Drugs (database searched by active ingredient). U.S. Food and Drug Administration. Accessed Oct 15, 2026
- MHRA Products: licensed-medicine search for "semax". Medicines and Healthcare products Regulatory Agency (UK). Accessed Oct 15, 2026
- MHRA Products: licensed-medicine search for "selank". Medicines and Healthcare products Regulatory Agency (UK). Accessed Oct 15, 2026
- EMA medicines data: centrally authorised human medicines (export of 14 October 2026). European Medicines Agency. Accessed Oct 15, 2026
- EMA Article 57 product data: medicines authorised in the EU/EEA (data as of 9 October 2026). European Medicines Agency. Accessed Oct 15, 2026
- Drug Product Database online query (searched by active ingredient). Health Canada. Accessed Oct 15, 2026
- Therapeutic Goods (Poisons Standard—October 2026) Instrument 2026 (F2026L01327, registered 30 September 2026). Federal Register of Legislation, Australian Government. Accessed Oct 15, 2026
- World Anti-Doping Code International Standard: Prohibited List 2026 (in force 1 January 2026). World Anti-Doping Agency. Accessed Oct 15, 2026